These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 27855592)
1. Role of Allogeneic Stem Cell Transplant in the Treatment of Primary Myelofibrosis. Soyer N; Celik F; Tombuloglu M; Sahin F; Saydam G; Vural F Exp Clin Transplant; 2019 Feb; 17(1):93-96. PubMed ID: 27855592 [TBL] [Abstract][Full Text] [Related]
2. Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center. Cengiz Seval G; Civriz Bozdag S; Toprak SK; Kurt Yuksel M; Topcuoglu P; Arslan O; Demirer T; Gurman G; Beksac M; Ilhan O; Ozcan M Balkan Med J; 2023 May; 40(3):197-204. PubMed ID: 36959692 [TBL] [Abstract][Full Text] [Related]
3. Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment. Gergis U; Kuriakose E; Shore T; Mayer S; Mark T; Pearse R; Schuster M; Feldman E; Roboz G; Ritchie E; Scandura J; Wang H; Zhou XK; Silver RT; van Besien K Clin Lymphoma Myeloma Leuk; 2016 May; 16(5):297-303. PubMed ID: 27025789 [TBL] [Abstract][Full Text] [Related]
4. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A; Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030 [TBL] [Abstract][Full Text] [Related]
5. Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis. Ditschkowski M; Elmaagacli AH; Trenschel R; Gromke T; Steckel NK; Koldehoff M; Beelen DW Haematologica; 2012 Oct; 97(10):1574-81. PubMed ID: 22491742 [TBL] [Abstract][Full Text] [Related]
6. Retrospective study of allogeneic haematopoietic stem-cell transplantation for myelofibrosis. Lissandre S; Bay JO; Cahn JY; Porcher R; Cacheux V; Cabrespine A; Cornillon J; Cassinat B; Peffault de Latour R; Socie G; Robin M Bone Marrow Transplant; 2011 Apr; 46(4):557-61. PubMed ID: 21042309 [TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
8. Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. Decroocq J; Itzykson R; Vigouroux S; Michallet M; Yakoub-Agha I; Huynh A; Beckerich F; Suarez F; Chevallier P; Nguyen-Quoc S; Ledoux MP; Clement L; Hicheri Y; Guillerm G; Cornillon J; Contentin N; Carre M; Maillard N; Mercier M; Mohty M; Beguin Y; Bourhis JH; Charbonnier A; Dauriac C; Bay JO; Blaise D; Deconinck E; Jubert C; Raus N; Peffault de Latour R; Dhedin N Am J Hematol; 2018 Mar; 93(3):416-423. PubMed ID: 29226497 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Kröger N; Holler E; Kobbe G; Bornhäuser M; Schwerdtfeger R; Baurmann H; Nagler A; Bethge W; Stelljes M; Uharek L; Wandt H; Burchert A; Corradini P; Schubert J; Kaufmann M; Dreger P; Wulf GG; Einsele H; Zabelina T; Kvasnicka HM; Thiele J; Brand R; Zander AR; Niederwieser D; de Witte TM Blood; 2009 Dec; 114(26):5264-70. PubMed ID: 19812383 [TBL] [Abstract][Full Text] [Related]
10. Allogeneic stem cell transplantation for myelofibrosis patients aged ≥65 years. Daghia G; Zabelina T; Zeck G; von Pein UM; Christopeit M; Wolschke C; Ayuk F; Kröger N Eur J Haematol; 2019 Oct; 103(4):370-378. PubMed ID: 31306511 [TBL] [Abstract][Full Text] [Related]
11. Outcome after Transplantation According to Reduced-Intensity Conditioning Regimen in Patients Undergoing Transplantation for Myelofibrosis. Robin M; Porcher R; Wolschke C; Sicre de Fontbrune F; Alchalby H; Christopeit M; Cassinat B; Zabelina T; Peffault de Latour R; Ayuk F; Socié G; Kröger N Biol Blood Marrow Transplant; 2016 Jul; 22(7):1206-1211. PubMed ID: 26970380 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Different Conditioning Regimens of Haploidentical Hematopoietic Stem Cell Transplant in Patients With Acute Myeloid Leukemia. Jiang Y; Fang X; Sui X; Liu X; Li Y; Wang X; Xu H; Zhang L; Wang X Exp Clin Transplant; 2018 Dec; 16(6):736-744. PubMed ID: 29790457 [TBL] [Abstract][Full Text] [Related]
16. Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network. Laport GG; Wu J; Logan B; Bachanova V; Hosing C; Fenske T; Longo W; Devine SM; Nademanee A; Gersten I; Horowitz M; Lazarus HM; Riches ML; Biol Blood Marrow Transplant; 2016 Aug; 22(8):1440-1448. PubMed ID: 27118571 [TBL] [Abstract][Full Text] [Related]
17. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors. Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A single center experience. Schmohl JU; Groh C; Faul C; Vogel W; Möhle R; Wirths S; Schneidawind D; Kanz L; Bethge WA Ann Hematol; 2016 May; 95(6):973-83. PubMed ID: 27021303 [TBL] [Abstract][Full Text] [Related]
19. Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis. Le Bourgeois A; Mohr C; Guillaume T; Delaunay J; Malard F; Loirat M; Peterlin P; Blin N; Dubruille V; Mahe B; Gastinne T; Le Gouill S; Moreau P; Mohty M; Planche L; Lode L; Bene MC; Chevallier P Biol Blood Marrow Transplant; 2013 Jun; 19(6):934-9. PubMed ID: 23523970 [TBL] [Abstract][Full Text] [Related]